Friday, July 10, 2026
🇺🇸 FDA

pharma · Eczema · GERD (Heartburn, Regurgitation, and Dyspepsia) Frequency

Hong Kong Baptist

Hong Kong Baptist University

Hong Kong Baptist clinical programs — 18 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
18
Drugs
14
Patents
0
All projects Drug pipeline News & analysis
Intelligence · Clinical Programs

Hong Kong Baptist projects

18 ClinicalTrials.gov programs sponsored by Hong Kong Baptist.

Hong Kong Baptist has 18 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

18 programs

Clinical programs

  1. CKD-495 75mg

    Hong Kong Baptist University

    Gastritis

    phase 3 small molecule completed

    1 trial

  2. CKD-501 0.5mg

    Hong Kong Baptist University

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    2 trials

  3. A Master Ganoderma Detox Tea

    Hong Kong Baptist University

    Eczema

    phase 2 other active

    1 trial

  4. Ceftriaxone 1000mg + doxycycline 100 mg

    Hong Kong Baptist University

    Neisseria Gonorrhoeae Infection

    phase 2 small molecule completed

    1 trial

  5. MaZiRenWan (MZRW)

    Hong Kong Baptist University

    Functional Gastrointestinal Disorders

    phase 2 small molecule completed

    1 trial

  6. ZL-1102 1% w/w gel BID for 16 weeks

    Hong Kong Baptist University

    Plaque Psoriasis

    phase 2 small molecule active

    1 trial

  7. mutual support group

    Hong Kong Baptist University

    Schizophrenia

    phase 2 other completed

    1 trial

  8. CKD-371

    Hong Kong Baptist University

    Type II Diabetes Mellitus

    phase 1 small molecule completed

    1 trial

  9. CKD-381

    Hong Kong Baptist University

    GERD

    phase 1 small molecule completed

    1 trial

  10. CKD-393 formulation I

    Hong Kong Baptist University

    Type II Diabetes

    phase 1 small molecule completed

    1 trial

  11. CKD-581

    Hong Kong Baptist University

    Myeloma, Multiple

    phase 1 small molecule active

    1 trial

  12. glargine + exenatide

    Hong Kong Baptist University

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  13. Anvitra Gastric Suspension

    Hong Kong Baptist University

    GERD (Heartburn, Regurgitation, and Dyspepsia) Frequency

    other completed

    1 trial

  14. BioAmicus Complete

    Hong Kong Baptist University

    Infantile Colic

    other active

    1 trial

  15. Biolizin

    Hong Kong Baptist University

    Feeding and Eating Disorders of Childhood

    other active

    1 trial

  16. Prospan cough Syrup

    Hong Kong Baptist University

    Cough Severity

    small molecule completed

    1 trial

  17. Starch

    Hong Kong Baptist University

    Lens Opacity

    other completed

    1 trial

  18. trans-resveratrol

    Hong Kong Baptist University

    Eye Disease

    small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Hong Kong Baptist have?

18 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.